Clinical Trial Update: Ph II Cabazitaxel DD Liposarcoma [Phase 2]

View source ↗

Summary

Phase II trial update for cabazitaxel in dedifferentiated liposarcoma (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma

Drugs mentioned

• Cabazitaxel (cabazitaxel)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Dedifferentiated Liposarcoma | Phase 2 | Status: COMPLETED